[1]
|
Shi, Y., Seto, E., Chang, L.S. and Shenk, T. (1991) Transcriptional Repression by YY1, a Human GLI-Krüppel-Related Protein, and Relief of Repression by Adenovirus E1A Protein. Cell, 67, 377-388.
https://doi.org/10.1016/0092-8674(91)90189-6
|
[2]
|
Park, K. and Atchison, M.L. (1991) Isolation of a Candidate Repressor/Activator, NF-E1 (YY-1, Delta), That Binds to the Immunoglobulin Kappa 3’ Enhancer and the Immunoglobulin Heavy-Chain muE 1 Site. Proceedings of the National Academy of Sciences of the United States of America, 889, 9804-9808. https://doi.org/10.1073/pnas.88.21.9804
|
[3]
|
Zhang, S., Sun, K., Zheng, R., et al. (2020) Cancer Incidence and Mortality in China, 2015. Journal of the National Cancer Center, 1, 2-11. https://doi.org/10.1016/j.jncc.2020.12.001
|
[4]
|
Castellano, G., Torrisi, E., Ligresti, G., et al. (2010) Yin Yang 1 Overexpression in Diffuse Large B-Cell Lymphoma Is Associated with B-Cell Transformation and Tumor Progression. Cell Cycle, 9, 557-563.
https://doi.org/10.4161/cc.9.3.10554
|
[5]
|
Gordon, S., Akopyan, G., Garban, H. and Bonavida, B. (2006) Transcription Factor YY1: Structure, Function, and Therapeutic Implications in Cancer Biology. Oncogene, 25, 1125-1142. https://doi.org/10.1038/sj.onc.1209080
|
[6]
|
Deng, Z., Cao, P., Wan, M.M. and Sui, G. (2010) Yin Yang 1: A Multifaceted Protein beyond a Transcription Factor. Transcription, 1, 81-84. https://doi.org/10.4161/trns.1.2.12375
|
[7]
|
Seto, E., Shi, Y. and Shenk, T. (1991) YY1 Is an Initiator Sequence-Binding Protein That Directs and Activates Transcription in Vitro. Nature, 354, 241-245. https://doi.org/10.1038/354241a0
|
[8]
|
Hariharan, N., Kelley, D.E. and Perry, R.P. (1991) Delta, a Transcription Factor That Binds to Downstream Elements in Several Polymerase II Promoters, Is a Functionally Versatile Zinc Finger Protein. Proceedings of the National Academy of Sciences of the United States of America, 88, 9799-9803. https://doi.org/10.1073/pnas.88.21.9799
|
[9]
|
Flanagan, J.R., Becker, K.G., Ennist, D.L., Gleason, S.L., Driggers, P.H., Levi, B.Z., et al. (1992) Cloning of a Negative Transcription Factor That Binds to the Upstream Conserved Region of Moloney Murine Leukemia Virus. Molecular and Cellular Biology, 12, 38-44. https://doi.org/10.1128/MCB.12.1.38
|
[10]
|
王婷, 郭倩倩, 杨月, 郑禄枫, 奚涛. 转录因子Yin Yang 1在肿瘤中的研究进展[J]. 药学进展, 2021, 45(3): 212-221.
|
[11]
|
Gordon, S. (2006) Transcription Factor YY1: Structure, Function, and Therapeutic Implications in Cancer Biology. Oncogene, 25, 1125-1142. https://doi.org/10.1038/sj.onc.1209080
|
[12]
|
Yao, Y.L., Yang, W.M. and Seto, E. (2001) Regulation of Transcription Factor YY1 by Acetylation and Deacetylation. Molecular and Cellular Biology, 27, 5979-5991. https://doi.org/10.1128/MCB.21.17.5979-5991.2001
|
[13]
|
Morales-Martinez, M., Valencia-Hipolito, A., Vega, G.G., et al. (2019) Regulation of Krüppel-Like Factor 4 (KLF4) Expression through the Transcription Factor Yin-Yang 1 (YY1) in Non-Hodgkin B-Cell Lymphoma. Oncotarget, 10, 2173-2188. https://doi.org/10.18632/oncotarget.26745
|
[14]
|
Makhlouf, M., Ouimette, J.F., Oldfield, A., et al. (2014) A Prominent and Conserved Role for YY1 in Xist Transcriptional Activation. Nature Communications, 5, Article No. 4878. https://doi.org/10.1038/ncomms5878
|
[15]
|
Dong, X.P. and Pfister, H. (1999) Overlapping YY1- and Aberrant SP1-Binding Sites Proximal to the Early Promoter of Human Papillomavirus Type 16. Journal of General Virology, 80, 2097-2101.
https://doi.org/10.1099/0022-1317-80-8-2097
|
[16]
|
Deng, Z., Wan, M., Cao, P., et al. (2009) Yin Yang 1 Regulates the Transcriptional Activity of Androgen Receptor. Oncogene, 28, 3746-3757. https://doi.org/10.1038/onc.2009.231
|
[17]
|
Gronroos, E., Terentiev, A.A., Punga, T., et al. (2004) YY1 Inhibits the Activation of the p53 Tumor Suppressor in Response to Genotoxic Stress. Proceedings of the National Academy of Sciences of the United States of America, 101, 12165-12170. https://doi.org/10.1073/pnas.0402283101
|
[18]
|
Sarvagalla, S., Kolapalli, S.P. and Vallabhapurapu, S. (2019) The Two Sides of YY1 in Cancer: A Friend and a Foe. Frontiers in Oncology, 9, Article No. 1230. https://doi.org/10.3389/fonc.2019.01230
|
[19]
|
Ramsay, R.G., Barton, A.L. and Gonda, T.J. (2003) Targeting c-Myb Expression in Human Disease. Expert Opinion on Therapeutic Targets, 7, 235-248. https://doi.org/10.1517/14728222.7.2.235
|
[20]
|
Fry, E.A. and Inoue, K. (2019) c-MYB and DMTF1 in Cancer. Cancer Investigation, 37, 46-65.
https://doi.org/10.1080/07357907.2018.1550090
|
[21]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674.
https://doi.org/10.1016/j.cell.2011.02.013
|
[22]
|
Sui, G., Affarel, B., Shi, Y., et al. (2004) Yin Yang 1 Is a Negative Regulator of p53. Cell, 117, 859-872.
https://doi.org/10.1016/j.cell.2004.06.004
|
[23]
|
Khachigian, L.M. (2018) The Yin and Yang of YY1 in Tumor Growth and Suppression. International Journal of Cancer, 143, 460-465. https://doi.org/10.1002/ijc.31255
|
[24]
|
Riggs, K.J., Saleque, S., Wong, K.K., et al. (1993) Yin-Yang 1 Activates the c-myc Promoter. Molecular and Cellular Biology, 13, 7487-7495. https://doi.org/10.1128/mcb.13.12.7487-7495.1993
|
[25]
|
Zhang, Q., Wan, M., Shi, J., et al. (2016) Yin Yang 1 Promotes mTORC2-Mediated AKT Phosphorylation. Journal of Molecular Cell Biology, 8, 232-243. https://doi.org/10.1093/jmcb/mjw002
|
[26]
|
Cairns, R.A., Harris, I.S. and Mak, T.W. (2011) Regulation of Cancer Cell Metabolism. Nature Reviews Cancer, 11, 85-95. https://doi.org/10.1038/nrc2981
|
[27]
|
周宇会, 魏九峰, 李国东, 刘明. Warburg效应在肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2017, 44(10): 762-766.
|
[28]
|
Gorrini, C., Harris, I.S. and Mak, T.W. (2013) Modulation of Oxidative Stress as an Anticancer Strategy. Nature Reviews Drug Discovery, 12, 931-947. https://doi.org/10.1038/nrd4002
|
[29]
|
Diehn, M., Cho, R.W., Lobo, N.A., Kalisky, T., Dorie, M.J., Kulp, A.N., Qian, D., Lam, J.S., Ailles, L.E., Wong, M., Joshua, B., Kaplan, M.J., Wapnir, I., Dirbas, F.M., Somlo, G., Garberoglio, C., Paz, B., Shen, J., Lau, S.K., Quake, S.R., Brown, J.M., Weissman, I.L. and Clarke, M.F. (2009) Association of Reactive Oxygen Species Levels and Radioresistance in Cancer Stem Cells. Nature, 458, 780-783. https://doi.org/10.1038/nature07733
|
[30]
|
Huang, T., Wang, G., Yang, L., et al. (2017) Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1. DNA and Cell Biology, 36, 947-958. https://doi.org/10.1089/dna.2017.3857
|
[31]
|
Zhang, J., Li, N., Fu, J., et al. (2020) Long Noncoding RNA HOTAIR Promotes Medulloblastoma Growth, Migration and Invasion by Sponging miR-1/miR-206 and Targeting YY1. Biomedicine & Pharmacotherapy, 124, Article ID: 109887. https://doi.org/10.1016/j.biopha.2020.109887
|
[32]
|
Erkeland, S.J., Valkhof, M., Heijmans-Antonissen, C., et al. (2003) The Gene Encoding the Transcriptionalregulator Yin Yang 1 (YY1) Is a Myeloid Transforming Gene Interfering with Neutrophilic Differentiation. Blood, 101, 1111-1117.
https://doi.org/10.1182/blood-2002-04-1207
|
[33]
|
Grubach, L., Juhl-Christensen, C., Rethmeier, A., et al. (2008) Gene Expression Profiling of Polycomb, Hox and Meis Genes in Patients with Acute Myeloid Leukaemia. European Journal of Haematology, 81, 112-122.
https://doi.org/10.1111/j.1600-0609.2008.01083.x
|
[34]
|
Chen, Y., Jacamo, R., Konopleva, M., et al. (2013) CXCR4 Downregulation of let-7a Drives Chemoresistance in Acute Myeloid Leukemia. Journal of Clinical Investigation, 123, 2395-2407. https://doi.org/10.1172/JCI66553
|
[35]
|
Riordan, J.R. and Ling, V. (1985) Genetic and Biochemical Characterization of Multidrug Resistance. Pharmacology & Therapeutics, 28, 51-75. https://doi.org/10.1016/0163-7258(85)90082-8
|
[36]
|
Antonio-Andres, G., Rangel-Santiago, J., Tirado-Rodriguez, B., et al. (2018) Role of Yin Yang-1 (YY1) in the Transcription Regulation of the Multi-Drug Resistance (MDR1) Gene. Leukemia & Lymphoma, 59, 2628-2638.
https://doi.org/10.1080/10428194.2018.1448083
|
[37]
|
Lobo, N.A., Shimono, Y., Qian, D. and Clarke, M.F. (2007) The Biology of Cancer Stem Cells. Annual Review of Cell and Developmental Biology, 23, 675-699. https://doi.org/10.1146/annurev.cellbio.22.010305.104154
|
[38]
|
Bonavida, B., Huerta-Yepez, S., Baritaki, S., et al. (2011) Overexpression of Yin Yang 1 in the Pathogenesis of Human Hematopoietic Malignancies. Critical Reviews™ in Oncogenesis, 16, 261-267.
https://doi.org/10.1615/CritRevOncog.v16.i3-4.90
|
[39]
|
Huerta-Yepez, S., Rivera-Pazos, C., Libra, M., et al. (1900) Prognostic Significance of Both the Cytoplasmic and Nuclear Overexpression of Yin-Yang 1 (YY1) among Patients with Multiple Myeloma (MM). Blood, 112, 2730.
https://doi.org/10.1182/blood.V112.11.2730.2730
|
[40]
|
Sandison, H.E., Usher, S., Karimiani, E.G., et al. (2013) PLK1 and YY1 Interaction in Follicular Lymphoma Is Associated with Unfavourable Outcome. Journal of Clinical Pathology, 66, 764-767.
https://doi.org/10.1136/jclinpath-2013-201461
|